Chemistry: molecular biology and microbiology – Vector – per se
Patent
1994-06-30
1999-03-09
Crouch, Deborah
Chemistry: molecular biology and microbiology
Vector, per se
435325, 935 70, C12N 500, C12N 1500
Patent
active
058799338
ABSTRACT:
A process for the transfer and/or expression of any gene into cells, organisms or species is disclosed. The process involves isolating the gene, introducing the gene into a vector comprised of at least one retrotransposon genetic element to provide a hybrid gene. The hybrid gene is introduced into a donor cell capable of packaging and transmitting the retrotransposon to other cells, organisms or species. The hybrid gene is transferred to a recipient cell wherein the hybrid gene replicates by reverse transcription and is inserted into the recipient cell's genome. The gene is preferably expressed as RNA and/or protein, giving the phenotype of the gene.
REFERENCES:
patent: 4405712 (1983-09-01), Woude et al.
patent: 4615974 (1986-10-01), Kingsman et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4670388 (1987-06-01), Rubin et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4719177 (1988-01-01), Baltimore et al.
patent: 4828987 (1989-05-01), Kophick et al.
patent: 4861719 (1989-08-01), Miller
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4898823 (1990-02-01), Kingsman et al.
patent: 4918166 (1990-04-01), Kingsman et al.
patent: 4957865 (1990-09-01), Samarut et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5354674 (1994-10-01), Hodgson
Muligan (1993) Science 260, 926-932.
Raffo et al (1991)Virolog 184, 277-289.
Marshall, Science, Science, 269, 1995, 1050-1055.
Culver et al., TIG, 10(5), 1994, 174-178.
Miller et al., FASEB. J., 9, 1995, 190-199.
Hodgson, Exp. Opin. Ther. Pat., 5(5), 1995, 459-468.
Chakraborty, A.K. et al. "Synthetic retrotransposon vectors for gene therapy," FASAB Journal 7: 971-977 (1993).
Chakraborly, A.K. et al. "Expression of VL30 vectors in human cells that are targets for gene therapy," Biochem. Biophys. Res. Comm. 209(2) 677-83 (1995).
Kantoff, P. et al. "Expression of human adenosine deaminase in non-human primates after retrovirus-mediated gene transfer," J. Exp Med 166:219-234 (1987).
E. F. Wagner et al., entitled "The Human .beta.-Globin Gene And A Functional Viral Thymidine Kinase Gene In Developing Mice", Proc. Natl. Acad. Sci. USA, 78, No. 8, pp. 5016-5020, (Aug. 1981).
S.A. Rosenberg, M.D., Ph.D., et al., "Gene Transfer Into Humans--Immunotherapy of Patients With Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified By Retroviral Gene Transduction", The New England Journal of Modicine, 323, No. 9, pp. 570-578, (Aug. 30, 1990).
J.D. Boeke et al., "A General Method for the Chromosomal Amplification of Genes in Yeast," Science, 239, 280 (15 Jan. 1988).
D.N. Foster et al., Proc. Nat'l Acad. Sci. USA, 79, 7317-7321 (1982).
D.N. Foster et al., "Isolation of Mouse DNA Segments Containing Epidermal Growth Factor (EGF) Inducible Sequences," J. Cell Biochem., (Suppl.) 6, 285 (1982).
C.P. Giri et al., "Discrete Regions of Sequence Homology Between Cloned Rodent VL30 Genetic Elements and AKV-related MuLV provirus Genomes," Nucleic Acids Research, 11, 305 (1983).
C.P. Hodgson et al., "The Long Terminal Repeats and Associated Flanking Sequences of a Mouse Virus-Like Genetic Element," DNA, 2, 83 (1983).
C.P. Hodgson et al., "Nucleotide Sequence of Mouse Virus-Like (VL30) Retrotransposon BVL-1," Nucleic Acids Research, 18, 673 (1990).
C.P. Hodgson et al., "Structure and Expression of Mouse VL30 Genes," Molecular and Cellular Biology, 3, 2221-2231 (Dec. 1983).
C.P. Hodgson et al., "Mouse Retrovirus-Like (VL30) Transposable Element RNA is Abundantly Expressed in PSI-2 Helper Cells, Transferred to Recipient Rat Hepatoma Cells, and Expressed in a Dexamethasone-Inducible Fashion Along with Specifically Vectored Sequences: Complete Structure," J. Cellu. Biochem., 13D, 54 (1989).
C.P. Hodgson et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene," Dissertation Abstracts International, 44, 700B (1983).
C.P. Hodgson et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene," Doctoral Dissertation, University of Minnesota, Feb., 1983.
R. Jaenisch, "Germ Line Integration and Mendelian Transmission of the Exogenous Moloney Leukemia Virus," Proc. Nat. Acad. Sci. USA, 73, 1260-1264.
R. Jaenisch et al., "Chromosomal Position and Activation of Retroviral Genomes Inserted into the Germ Line of Mice," Cell, 24, 519-529 (May 1981).
Patent Search: Genetic Vectors, Transduction, Genetic Transfection (Oct. 1990) (a copy of a computer generated search was submitted with the PTO 1449 of the parent application).
Rotman et al., Nucl. Acid Res., 14, 645-658 (1986).
P. Singleton et al., Dictionary of Microbiology and Molecular Biology, 753 (1987 ed.).
H.M. Temin, "Retrovirus Variation and Evolution," Genome, 31, 17-22 (1989).
R. Jaenisch, "Transgenic Animals", Science, vol. 240, pp. 1468-1474, Jun. 1988.
A.D. Miller, "Human Gene Therapy Comes of Age", Nature, Vo. 357, pp. 455-460, Jun. 11, 1992.
Crouch Deborah
Nature Technology Corporation
LandOfFree
Mammalian Retrotransposons does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian Retrotransposons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian Retrotransposons will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1319926